Cargando…
Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram
BACKGROUND: Before therapeutic effect is obtained after treatment with antidepressant drugs, like serotonin selective reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAO-Is) there is an initial lag-period of a few weeks. Neuronal adaptations on a molec...
Autores principales: | Berggard, Cecilia, Damberg, Mattias, Oreland, Lars |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC547915/ https://www.ncbi.nlm.nih.gov/pubmed/15663788 http://dx.doi.org/10.1186/1471-2210-5-1 |
Ejemplares similares
-
Phenelzine treatment increases transcription factor AP-2 levels in rat brain
por: Damberg, Mattias, et al.
Publicado: (2003) -
Does the transcription factor AP-2β have an impact on the genetic and early environmental influence on ethanol consumption?
por: Oreland, S., et al.
Publicado: (2010) -
Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine
por: Matveychuk, Dmitriy, et al.
Publicado: (2021) -
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
por: Hinz, Marty, et al.
Publicado: (2014) -
A Selective Phenelzine Analogue Inhibitor of Histone
Demethylase LSD1
por: Prusevich, Polina, et al.
Publicado: (2014)